News
On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...
BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.
Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.
Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.
Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results